Hypercoagulable states

References

• Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987: 317(16): 991–6
   PubMed Web of Science ®Google Scholar
• Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. N Engl J Med 1983: 309(6): 340–4
   PubMed Web of Science ®Google Scholar
• Coller BS, Owen J, Jesty J, et al. Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis 1987: 7(5): 456–62
   PubMedGoogle Scholar
• Hartman KR, Manco-Johnson M, Rawlings JS, et al. Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol Oncol 1989: 11(4): 395–401
   PubMedGoogle Scholar
• Vigano D'Angelo S, Comp PC, Esmon CT, et al. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest 1986: 77(2): 416–25
   PubMed Web of Science ®Google Scholar
• McGehee WG, Klotz TA, Epstein DJ, et al. Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med 1984: 101 (1): 59–60
   PubMed Web of Science ®Google Scholar
• Comp PC, Doray D, Patton D, et al. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986: 67(2): 504–8
   PubMed Web of Science ®Google Scholar
• Engesser L, Broekmans AW, Briet E, et al. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987: 106(5): 677–82
   PubMed Web of Science ®Google Scholar
• Comp PC, Nixon RR, Cooper MR, et al. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984: 74(6): 2082–8
   PubMed Web of Science ®Google Scholar
• Grimaudo V, Gueissaz F, Hauert J, et al. Necrosis of skin induced by coumarin in a patient deficient in protein S. BMJ 1989: 298(6668): 233–4
   PubMedGoogle Scholar
• Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med 1975: 292(3): 146–51
   PubMed Web of Science ®Google Scholar
• Menache D. Replacement therapy in patients with hereditary antithrombin III deficiency. Semin Hematol 1991: 28(1): 31–8
   PubMed Web of Science ®Google Scholar
• Kauffmann RH, Veltkamp JJ, Van Tilburg NH, et al. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1978: 65(4): 607–13
   PubMedGoogle Scholar
• Sagar S, Stamatakis JD, Thomas DP, et al. Oral contraceptives, antithrombin-III activity, and postoperative deep-vein thrombosis. Lancet 1976: 1(7958): 509–11
   PubMed Web of Science ®Google Scholar
• Conley CL, Haretmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952: 31(6): 621–2
   Web of Science ®Google Scholar
• Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med 1990: 112(9): 682–98
   PubMed Web of Science ®Google Scholar
• Carreras LO, Vermylen JG. “Lupus” anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 1982: 48(1): 38–40
   PubMed Web of Science ®Google Scholar
• De Wolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982: 142(7): 829–34
   PubMed Web of Science ®Google Scholar
• Kalunian KC, Peter JB, Middlekauff HR, et al. Clinical significance of a single test for anticardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988: 85(5): 602–8
   PubMed Web of Science ®Google Scholar
• Lubbe WF, Butler WS, Palmer SJ, et al. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983: 1 (8338): 1361–3
   PubMed Web of Science ®Google Scholar
• Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974: 81(Apr): 311–6
   PubMedGoogle Scholar
• Hume M, Turner RH, Kuriakose TX, et al. Venous thrombosis after total hip replacement: combined monitoring as a guide for prophylaxis and treatment. J Bone Joint Surg (Am) 1976: 58(7): 933–9
   PubMed Web of Science ®Google Scholar
• Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bed-rest. Br J Surg 1957: 45(191): 209–26
   PubMed Web of Science ®Google Scholar
• Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism: an overview. Chest 1986: 89(5 Suppl): 374–83S
   PubMed Web of Science ®Google Scholar
• Pechet L, Alexander B. Increased clotting factors in pregnancy. N Engl J Med 1961: 265(Nov 30): 1093–7
   PubMed Web of Science ®Google Scholar
• Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983: 62(1): 14–31
   PubMed Web of Science ®Google Scholar
• Bick RL. Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management. Semin Thromb Hemost 1978: 5(1): 1–26
   PubMed Web of Science ®Google Scholar
• Patterson WP, Ringenberg QS. The pathophysiology of thrombosis in cancer. Semin Oncol 1990: 17(2): 140–6
   PubMed Web of Science ®Google Scholar
• Mammen EF. Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol 1982: 142(6 Pt 2): 781–90
   PubMed Web of Science ®Google Scholar
• Marciniak E, Gockerman JP. Heparin-in-duced decrease in circulating antithrombin-III. Lancet 1977: 2(8038): 581–4
   PubMed Web of Science ®Google Scholar
• Mason JW, Colman RW. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. Thromb Diath Haemorrh 1971: 26(2): 325–31
   PubMedGoogle Scholar